Molecular pathways:The future of research at NIBR

See how scientists at the Novartis Institutes for BioMedical Research, have embraced a new way of thinking about disease that looks at the role of molecular pathways. This new approach has changed drug discovery at Novartis, and prompted a major shift in the way Novartis scientists understand disease and disease therapies.
Learn more at www.nibr.com
© 2011 Novartis AG

[@mmnasir1000]

Thank you Novartis. You have been a pioneer in drug research and development.

[@sjamesparsonsjr]

What software is being used at 1:15?

[@uppumanesh5767]

It looks a bit like UCSF Chimera